Zenith Drugs Fair Value
Fair Value Analysis Export
P/B Based Valuation
Asset-Based Valuation
ZENITHDRUG Fair Value Analysis — Data Sources & Coverage
Zenith Drugs financial data sources, valuation methods applied and sector benchmarks used. Analyse ZENITHDRUG ownership pattern to track promoter, FII and institutional holdings.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
ZENITHDRUG vs Healthcare Sector Peers — P/E, P/B & Market Cap
Zenith Drugs P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Accretion Pharmaceuticals | ACCPL | 14.17 | 2.14 | ₹100 |
| Jeena Sikho Lifecare | JSLL | 41.45 | 23.68 | ₹8,396 |
| Par Drugs & Chemical | PAR | 8.21 | 1.07 | ₹114 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Sat Kartar Life | SATKARTAR | 32.1 | 6.11 | ₹320 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.